Adoptive transfer of antigen-specific T cells is an attractive strategy for the treatment of hematologic malignancies. It has been shown that T cells recognizing minor histocompatibility antigens (mHag) selectively expressed on hematopoietic cells mediate antileukemic reactivity after allogeneic stem cell transplantation. However, large numbers of T cells with defined specificity are difficult to attain. An attractive strategy to obtain large numbers of leukemia-reactive T cells is retroviral transfer of mHag-specific T-cell receptors (TCR). TCR transfer into T cells specific for persistent viruses may enable these T cells to proliferate both after encountering with viral antigens as well as mHags, increasing the possibility of in vivo survival. We analyzed whether the dual specificity of the TCR-transferred T cells after repetitive stimulation via either the introduced antileukemic HA-2-TCR or the endogenous cytomegalovirus (CMV) specific CMV-TCR was preserved. We show that after repetitive stimulation, T cells skew to a population predominantly expressing the triggered TCR. However, HA-2-TCR-transferred CMV-specific T cells with high antileukemic HA-2-TCR expression but low CMV-TCR expression were able to persist and proliferate after repetitive stimulation with pp65. Moreover, HA-2-TCR-transferred CMVspecific T cells remained dual specific after repetitive stimulation and TCR expression could be reverted after additional stimulation via the previously nonstimulated TCR, restoring high-avidity interactions. These data imply persistence of TCR-transferred virus-specific T cells with both antileukemic and antivirus reactivity in vivo.
Introduction
Patients with relapsed hematologic malignancies after HLAmatched allogeneic stem cell transplantation can be successfully treated with donor lymphocyte infusion (1, 2) . However, the beneficial graft versus leukemia (GVL) effect of donor lymphocytes is frequently accompanied by graft-versus-host disease (GVHD). GVL as well as GVHD seem to be caused by T cells that are capable of recognizing mHags on patient cells (3) (4) (5) . Minor histocompatibility antigens (mHags) are immunogenic peptides derived from polymorphic proteins presented in the context of HLA molecules that are disparate between donor and recipient. T-cell responses against ubiquitously expressed mHags may be responsible for both GVL and GVHD. T cells reactive with mHags selectively expressed on cells of the hematopoietic lineage may solely mediate GVL reactivity. HA-2 and HA-1 are examples of mHags selectively expressed in cells of the hematopoietic system and are presented in an HLA-class I-restricted fashion (6, 7) .
To separate the beneficial GVL from GVHD, adoptive transfer of T cells recognizing mHags selectively expressed on cells of the hematopoietic system is a promising strategy. However, therapeutic cell numbers of mHag-specific T cells are difficult to attain. An attractive alternative would be to equip T cells with mHag-specific T-cell receptors (TCR) via retroviral gene transfer. Different studies have shown the effectiveness of TCR-transferred T cells in vitro (8) (9) (10) (11) (12) and in vivo (13) (14) (15) . Redirected T cells were able to produce cytokines and exhibited Ag-specific cytolytic activity when triggered via the introduced TCR. Moreover, in mouse models, it was shown that redirected T cells could be activated via their introduced TCR, home to effector sites, and eradicate tumors. Recently, Rosenberg and colleagues (14) showed in a clinical trial the feasibility of adoptive transfer of TCR-engineered T cells in melanoma patients.
In most TCR gene transfer studies, unselected peripheral blood T cells were used as recipient T cells. Transfer of TCRs into an unselected pool of T cells may lead to transduction into regulatory T cells capable of impairing the antileukemic immune reaction. Furthermore, in a pool of T cells with a diverse TCR repertoire, a high number of different mixed TCR dimers with unknown specificity can be formed due to pairing of the retrovirally introduced TCR chains with the endogenously expressed TCR chains, increasing the probability of the formation of autoreactive mixed TCR dimers. Therefore, we previously proposed TCR transfer into virus-specific T cells (16) because selection of these Ag-specific CD8 T cells leads to exclusion of regulatory T cells. In addition, virus-specific memory T cells generally consist of an oligoclonal population with restricted TCRah usage (17) (18) (19) (20) (21) , minimizing the number of different mixed TCR dimers that can be formed. Furthermore, adoptive immunotherapy with EBV-specific T cells in patients with posttransplant proliferative disease and cytomegalovirus (CMV)-specific T cells as prophylaxis for CMV reactivation (22) (23) (24) in patients after stem cell transplantation has proven to be a therapeutic strategy without toxicity or GVHD. Because EBV and CMV are examples of latent viruses, we hypothesize that due to frequent encounter with viral antigens and subsequent triggering of the endogenous TCR, TCR-transferred virus-specific T cells will survive for a prolonged period of time in vivo. Moreover, it was recently shown in a mouse model that tolerization of one TCR could be overcome by signaling via the other TCR. In this model, the function of the tolerized selftumor reactive TCR of dual-T-cell receptor transgenic T cells was rescued by proliferation induced via the virus-specific TCR, underlining the potency of TCR transfer into virus-specific T cells (25) .
We previously showed that CMV-specific T cells could be redirected into antileukemic T cells by transfer of TCRs directed against the mHag HA-2 without the loss of their original specificity. T cells were capable of exerting effector functions via their endogenous virus-specific TCR as well as via their introduced HA-2-specific TCR (16) . The TCR cell surface makeup on HA-2-TCR-transferred CMV-specific T cells, however, varied. T cells either highly expressed the endogenous TCR with a low expression of the introduced TCR, or highly expressed the introduced TCR with a low expression of the endogenous TCR, or expressed both TCRs intermediately at the cell surface. Different studies have shown that there is a threshold in expression of TCR complexes and costimulatory molecules needed for TCR signaling leading to proliferation (26, 27) . Although both the HA-2-TCR and CMV-TCR used in this study are high-affinity TCRs, it is likely that differential TCR expression leads to differences in avidity and thus in proliferation. For long-term protection, we hypothesize that proliferative capacity via both TCRs will be important. When patients relapse, mHags will be abundantly present. However, when there is only minimal residual disease (MRD), it may be expected that HA-2-TCR-transferred virus-specific T cells will primarily encounter viral antigens latently present in the recipient, as the HA-2 antigen is only expressed by recipient hematopoietic cells. When frequent encounter of viral antigens would lead to selective survival of HA-2-TCR-transferred CMV T cells predominantly expressing the CMV-TCR incapable of proliferating via the HA-2-TCR, persistence in vivo of HA-2-TCR-transferred CMV T cells capable of controlling MRD may fall short.
In this study, we analyzed the TCR expression, cytolytic potential, and proliferation of HA-2-TCR-transferred CMV-specific T cells after repetitive stimulation with the CMV-pp65 antigen or the HA-2 antigen. We show that TCR-transferred virus-specific T cells repetitively stimulated skewed to T cells predominantly expressing one TCR. However, HA-2-TCR-transferred CMV-specific T cells with high antileukemic HA-2-TCR expression but low CMV-TCR expression were able to persist after repetitive stimulation with pp65. Moreover, HA-2-TCR-transferred CMV-specific T cells preserved their functional activity via both TCRs after repetitive stimulation, and TCR expression could be reverted after additional stimulation, restoring high avidity functionality of both the endogenous CMV-TCR and the introduced antileukemic HA-2-TCR.
Materials and Methods
Construction of retroviral vectors and production of retroviral supernatant. The construction of retroviral vectors encoding for pp65 of HCMV AD169 and the TCR chains of the HA-2-reactive T-cell clone HA2.5 has been described previously (16) . Briefly, the HA-2-TCR AV15 and HA-2-TCR BV18 chains were cloned into bicistronic retroviral vectors encoding the marker genes eGFP and DNGF-R (28), respectively. As control vectors, retroviral vectors were used containing eGFP or DNGF-R only.
HLA class I tetrameric complexes and sorting by flow cytometry. Tetrameric HLA-A2 molecules in complex with CMV pp65-derived peptide NLVPMVATV (CMV tetramer) and the HA-2-derived peptide YIGEVLVSV (HA-2 tetramer) either phycoerythrin (PE)-or allophycocyanin (APC)-conjugated were constructed as previously described (29) with minor modifications. For flow cytometric analyses as well as fluorescenceactivated cell sorting (FACS), cells were labeled with tetramers for 1 h at 4jC in RPMI without phenol, supplemented with 2% fetal bovine serum (FBS), and washed twice or labeled with either anti-BV2 PE (Immunotech), or anti-DNGF-R either PE-conjugated (Pharmingen) or APC-conjugated (Cedarlane Laboratories) for 30 min at 4jC.
Cells. For all stimulations and functional experiments, EBV-transformed lymphoblastoid cell lines (EBV-LCL) were used of an HLA-identical sibling pair with HA-2 disparity. EBV-LCL Z is HLA-A2 positive but HA-2 negative (EBV-Z), whereas EBV-LCL RZ is HLA-A2 and HA-2 positive (EBV-RZ HA-2). To obtain EBV-LCLs presenting endogenously processed pp65, EBV-Z was transduced with the lower matrix protein pp65 of CMV (EBV-Z pp65). EBV LCLs were maintained in Iscove's modified Dulbecco's medium (IMDM) supplemented with 10% FBS. Malignant cells used in this study were chronic myeloid leukemia mononuclear cells (CML) CML-Z, which is HLA A2 positive but HA-2 negative, and CML-T, which is HLA A2 and HA-2 positive. CML cells were thawed 1 d before testing and cultured in IMDM supplemented with 10% FBS.
Virus-specific T cells were isolated from peripheral blood of healthy individuals using CMV tetramers, as previously described (16), and expanded in T-cell medium containing IMDM supplemented with 5% FBS, 5% human serum, and 100 IU/mL interleukin 2. T cells were nonspecifically stimulated using 800 ng/mL phytohemagglutinin (PHA; Murex Biotec Limited) and irradiated autologous feeder cells. The CMVspecific T cells were subsequently sorted using anti-BV2 PE, were nonspecifically restimulated, followed by retroviral transduction at day 2. For the transduction procedure, recombinant human fibronectin fragments CH-296 (30, 31) were used. HA-2-TCR-transduced BV2-positive T cells were FACS sorted based on eGFP and NGF-R positivity, and the cells were expanded in bulk. T cells were cultured in T-cell medium and either stimulated nonspecifically every 2 wk with feeder cell mixtures containing 1 Â 10 6 /mL irradiated allogeneic peripheral blood mononuclear cells (PBMC; 20 Gy) and 1 Â 10 5 /mL irradiated EBV-LCLs (50 Gy), or were repetitively stimulated with 1 Â 10 6 /mL irradiated HLA-A2-negative allogeneic PBMCs and 1 Â 10 5 /mL irradiated EBV-RZ HA-2 or EBV-Z pp65. Subsets of HA-2-TCR-transduced virus-specific T cells with various levels of TCR cell surface expression were sorted based on either high CMV-TCR and low HA-2-TCR expression using a combination of anti-BV2 monoclonal antibody (mAb) and HA-2 tetramer, or based on low CMV-TCR expression using only anti-BV2 mAb. No tetramers were used for positive selection because tetramer binding to the TCR can lead to specific stimulation (32) . Subsequently, sorted T cells were tested functionally either directly after sorting, or after 7 d of stimulation with pp65 or HA-2. This study was approved by the Leiden University Medical Center institutional review board.
Cytotoxicity assay and PKH-26 based proliferation assay. Cytotoxicity assay was performed as previously described (16) using a standard 4-h 51 Cr release assay at 10:1 effector-to-target ratios. The tests were done in duplicate. To test the capacity of T cells to specifically proliferate in response to antigen, T cells were labeled with PKH-26 according to manufacturer's instructions, and stimulated with different feeder cell mixtures containing 1 Â 10 6 /mL irradiated allogeneic HLA-A2-negative PBMCs in combination with 1 Â 10 5 /mL target cells. The targets used were as follows: EBV-Z either unpulsed or pulsed with 1 Ag/mL CMV-NLV or HA-2 YIG peptide, EBV-Z pp65, and EBV-RZ HA-2. Alternatively, T cells were stimulated nonspecifically by adding PHA. PKH dilution was analyzed at day 4 after stimulation using flow cytometry.
Results
Skewing of TCR cell surface makeup upon specific TCR triggering. We hypothesize that for long-term protection, the capacity of TCR-transferred virus-specific T cells to proliferate and exert effector functions in response to triggering via each TCR is important. Therefore, we studied whether repetitive Ag-specific stimulation of these dual-specific T cells resulted in skewing of T cells to a population predominantly expressing one TCR, incapable of exerting effector functions via the other TCR. For this purpose, T cells recognizing the pp65 protein of CMV in the context of HLA-A2 (pp65-NLV) were isolated from PBMCs of healthy CMV seropositive individuals, transduced with the mHag-specific HA-2-TCR, and sorted on basis of marker gene expression. These TCR-transferred virus-specific T cells showed differences in TCR cell surface makeup, which was stable for months after repetitive nonspecific TCR triggering. The T cells expressed either both TCRs at intermediate levels at the cell surface, or the endogenous TCR was highly expressed with a low expression of the introduced TCR, or the introduced TCR was highly expressed with a low expression of the endogenous TCR (Fig. 1A) . These HA-2-TCR-transferred CMV T cells exerted cytolytic activity directed against HA-2-expressing EBV-LCLs, as well as against mononuclear CML cells expressing HA-2 (Fig. 1B) . To test whether all different T-cell subpopulations were able to persist after repetitive stimulation with either pp65 or HA-2, the dual-specific T cells were stimulated with EBV-LCLs expressing either endogenously pp65 or HA-2. Differences in TCR expression were measured at day 7 after stimulation using CMV and HA-2 tetramers (Fig. 1C) . A gradual decrease in HA-2-TCR expression was observed after repetitive stimulation with pp65. Likewise, a gradual decrease in CMV-TCR expression was observed after repetitive stimulation with HA-2, whereas HA-2-TCR expression increased. To study whether changes in TCR expression could be reversed by changing the stimulation, T cells that were stimulated twice with pp65 were stimulated alternatively with HA-2. Likewise, T cells that were stimulated twice with HA-2 were stimulated alternatively with pp65. The results show that by Ag-specific triggering of the previously nontriggered TCR the TCR expression rapidly reverted (Fig. 1C) . On bases of the changed TCR makeup (Fig. 1D) , we tested the HA-2 TCR-transferred virus-specific T cells stimulated repetitively with either only pp65 or only HA-2 for Ag-specific cytotoxic capacity (Fig. 1E) . Both T-cell populations were capable of killing HA-2 peptide-loaded target cells, but the cytolytic activity of HA-2-TCRtransduced T cells repetitively stimulated with pp65 directed against target cells endogenously expressing HA-2 (RZ HA-2) was reduced. This was in accordance with the TCR expression because in the T-cell population repetitively stimulated with pp65, only low numbers of HA-2 tetramer-positive T cells were present, whereas in the T-cell population repetitively stimulated with HA-2, still significant numbers of CMV tetramer-positive T cells were present. These data illustrate that repetitive stimulation of HA-2-TCRtransferred CMV-specific T cells with either HA-2 or CMV pp65 antigen resulted in preferential TCR expression of the triggered TCR, whereas expression of the nontriggered TCR gradually decreased. However, the T cells with either predominant CMV or HA-2-TCR expression preserved their dual specificity, although the level of reactivity in response to activation of the triggered TCR was higher than via the nontriggered TCR. In addition, changes in TCR expression could rapidly be reverted by Ag-specific triggering of the previously nontriggered TCR.
Generation and functionality of opposing T-cell subsets. To be able to dissect whether the difference in TCR makeup after reverting the stimulation of T cells predominantly expressing one TCR was due to selective outgrowth or due to differential TCR distribution, these T cells were sorted into opposing subsets with either high CMV-TCR expression based on high CMV-TCR BV2 mAb staining and low HA-2 tetramer staining (CMV-TCR hi ; Fig. 2A ), or low CMV-TCR expression based on low CMV-TCR BV2 mAb staining (HA-2-TCR hi ; Fig. 2A ). No tetramers were used for positive selection of the T cells because binding of the tetramers to the TCR would result in Ag-specific triggering via either the CMV or HA-2-TCR (32). Directly after sorting, TCR expression of the sorted T-cell populations was analyzed using HA-2 tetramer and CMV-TCR BV2 mAb staining ( Fig. 2A) . Both sorted T-cell subsets were positive for the marker genes eGFP and NGF-R (Fig. 2B ). To investigate whether T cells almost exclusively expressing one TCR were still able to exert both HA-2 and pp65-specific cytolytic activity, the T cells were tested in a cytotoxicity assay directly after sorting (Fig. 2C) . The CMV-TCR hi T cells exerted efficient cytotoxic activity against both pp65-peptide-pulsed target cells and target cells endogenously expressing pp65, which was comparable with the mock-transduced CMV T cells. Although no HA-2-TCR expression could be measured on these T cells using HA-2 tetramers (Fig. 2A) , the cells were still cytotoxic against HA-2 peptide-pulsed target cells, but showed marginal cytotoxic activity against target cells endogenously expressing HA-2, indicating that these T cells only exhibit low avidity HA-2 reactivity (Fig. 2C) . The HA-2-TCR hi T cells efficiently lysed both HA-2 peptide-pulsed target cells as well as the endogenous HA-2-positive target cells. Only low CMV-TCR expression could be measured on these T cells, and the T cells still showed low cytotoxicity against pp65 peptidepulsed target cells but only marginal cytotoxicity against target cells endogenously expressing pp65.
To study whether the sorted opposing T-cell subsets were able to proliferate upon HA-2 and pp65-specific stimulation, the T cells were labeled with PKH-26 and analyzed using FACS at day 4. Both the CMV-TCR hi and HA-2-TCR hi T cells were able to proliferate after stimulation with pp65 peptide-pulsed EBV-LCLs or EBV-LCLs endogenously expressing pp65 (Fig. 3A and B) . Only a small percentage of the CMV-TCR hi T cells were capable of proliferating after stimulation with HA-2 peptide-pulsed EBV-LCLS or EBVLCLs endogenously expressing HA-2 ( Fig. 3A and B) . The proliferation of HA-2-TCR hi T cells stimulated with HA-2-positive EBV-LCLs was similar to the proliferation induced by pp65-positive EBV-LCLs. Because the HA-2-TCR hi T cells were capable of proliferating both after HA-2 and pp65-specific stimulation, specific outgrowth as the main cause of reverting TCR makeup was less plausible.
These results show that low CMV-TCR cell surface expression on HA-2-TCR hi T cells was sufficient for these cells to exert pp65 specific cytotoxic activity against pp65 peptide-pulsed target cells, as well as pp65-specific proliferation. The low HA-2-TCR expression on CMV-TCR hi T cells was sufficient for these cells to exert specific cytotoxic activity against HA-2 peptide-pulsed target cells but was not enough for HA-2-specific proliferation. Therefore, it seems that the threshold of the endogenous TCR to induce proliferation and cytotoxic reactivity is more easily reached than the threshold of the introduced TCR, underlining the importance of targeting T cells, which will encounter antigens that trigger their endogenous TCR in vivo to ensure persistence of TCR transferred T cells.
Opposing T-cell subsets redistribute TCR expression on their cell surface after additional stimulation. To test whether also the CMV-TCR hi and the HA-2-TCR hi -sorted T cells were able to change their TCR make up after different specific stimulations, 
CMV-TCR
hi -sorted T cells (Fig. 4A ) and HA-2-TCR hi -sorted T cells (Fig. 4B ) stimulated with EBV-LCLs presenting either endogenously processed pp65 or HA-2 were analyzed for TCR expression at day 7. After 7 days of Ag-specific stimulation CMV-TCR hi -sorted T cells re-expressed the HA-2-TCR after stimulation with pp65 or HA-2 (Fig. 4A ). Although stimulation with HA-2 was not robust enough to induce proliferation of the CMV-TCR hi -sorted T cells (Fig. 3) , it resulted in restored HA-2-TCR expression. Similarly, HA-2-TCR hisorted T cells re-expressed the CMV-TCR after stimulation with pp65 or HA-2 (Fig. 4B) . These results show that also in the sorted T-cell subsets with predominant CMV or HA-2-TCR expression, T cells are still capable of up-regulating their TCR expression after stimulation via either the endogenous or introduced TCR.
Since we observed redistribution of TCR cell surface expression 1 week after stimulation (Fig. 4) , we investigated in a cytotoxicity assay whether cytolytic activity of CMV-TCR hi or HA-2-TCR hisorted T cells was improved (Fig. 5) . After additional stimulation, only marginal differences in cytotoxic activity against HA-2 and pp65-positive target cells were observed between the CMV-TCR hi and HA-2-TCR hi T cells, corresponding with the restored coexpression of the HA-2 and CMV-TCR (Fig. 4) . All subsets displayed high cytotoxic activity against HA-2-positive and pp65-positive target cells, illustrating restored high avidity interactions.
To test whether the restored HA-2 and CMV-TCR coexpression also led to improved proliferation after stimulation via either endogenous or introduced TCR, the CMV-TCR hi and the HA-2-TCR hi T cells were labeled with PKH-26, stimulated again with HA-2 or pp65, and analyzed using FACS at day 4 (Fig. 5B) . All CMV-TCR hi T cells and HA-2-TCR hi T cells stimulated with pp65 or HA-2 were able to proliferate vigorously after a second stimulation with pp65-positive EBV-LCLs. In contrast to the minimal amount of proliferation after HA-2-specific stimulation directly after sorting (Fig. 3) , most CMV-TCR hi T cells stimulated once with HA-2 were capable of proliferating after a second HA-2-specific stimulation. A small part of the CMV-TCR hi T cells stimulated once with pp65 was not able to proliferate upon HA-2-specific stimulation.
In conclusion, opposing T-cell populations are able to redistribute their TCRs at the cell surface after an additional Ag-specific stimulation, leading to restored functionality via both TCRs. These data imply that no loss of dual specificity is likely to occur due to skewing of T cells to a population predominantly expressing one TCR.
Discussion
In this study, we show that TCR-transferred virus-specific T cells repetitively stimulated via one TCR remained dual reactive in response to triggering via both the endogenous and the introduced TCR. After repetitive stimulation of one TCR, TCR-transferred T cells preferentially expressed the triggered TCR, losing high avidity interaction via the previously nontriggered TCR. However, after a single stimulation via the previously nontriggered TCR, TCR expression reverted within 1 week. When the dual-specific T cells were sorted in opposing CMV-TCR hi T cells and HA-2-TCR hi T cells, both subsets still showed cytotoxic activity against HA-2 peptidepulsed target cells and CMV peptide-pulsed target cells, respectively, but limited cytotoxic activity against targets presenting endogenously processed antigen, indicating loss of high avidity interactions. After additional stimulation, both subsets were able to re-express the HA-2 and CMV-TCR, respectively. When TCR expression was redistributed on the T cells, high avidity functionality via both the endogenous and the introduced TCR was restored. Therefore, we speculate that also HA-2-TCR hi T cells are capable of persisting during MRD when HA-2-TCR-transferred CMV T cells will predominantly encounter viral antigens. Furthermore, we anticipate that HA-2-TCR-transferred CMV T cells after a long period of MRD are still able to gain antileukemic effector functions when the patient would relapse.
Directly after sorting, T cells predominantly expressed the CMV-TCR (CMV-TCR hi ) or the HA-2-TCR (HA-2-TCR hi ). However, after an additional stimulation, TCR re-expression was observed. Surprisingly, HA-2-TCR re-expression was observed on CMV hi TCR T cells both after stimulation with HA-2 as well as with pp65, and CMV-TCR re-expression was observed on HA-2-TCR hi T cells both after stimulation with pp65 as well as with HA-2. TCR make up on transduced T cells seems to be activation dependent; however, a trend of preferential redistribution of the TCR being triggered was observed. It has been described that upon activation, T cells enlarge and increase TCR expression (33) (34) (35) (36) , which is accompanied with restructuring compartmentalization of plasma membrane molecules (27, 37, 38) . Possibly, because of both increased TCR expression and localized high TCR density, HA-2-TCR on CMV-TCR hi T cells could be visualized using HA-2 tetramer staining after an additional stimulation, whereas this is not possible when HA-2-TCR is equally distributed along the cell membrane. Another possibility is that initial down-regulation of the triggered TCR enabled surface expression of intracellular TCRs consisting of both the endogenous and introduced TCRs, whereas later on TCR, expression will be dominated by newly synthesized previously triggered TCR. This would result in the preferential but not exclusive re-expression of the triggered TCR. It is evident that despite low CMV-TCR expression, HA-2-TCR hi T cells are capable of persisting during repetitive stimulation with pp65, although they do not proliferate as vigorously after stimulation with pp65 as CMV-TCR hi T cells. Even in a stringent selection of T cells with predominant expression of either the introduced or the endogenous TCR, re-expression of the other TCR was observed, implying that TCR expression on these T cells is dynamic rather than static.
Our results indicate that the threshold of the endogenous TCR to induce proliferation and cytotoxic reactivity is more easily reached than the threshold of the introduced TCR, underlining the importance of targeting T cells, which will encounter antigens that trigger their endogenous TCR in vivo to ensure persistence of TCR-transferred T cells. EBV and CMV are viruses that latently persist after initial infection and have to be continuously controlled by the immune system. Both in immunocompetent and immunocompromised hosts, immune responses result in viral containment in latent stage rather than virus eradication (39) (40) (41) . Therefore, we propose to use EBV or CMV-specific T cells as host cells for TCR transfer. When there is only MRD, it may be expected that HA-2-TCR-transferred virus-specific T cells will primarily encounter viral antigens latently present in the recipient, as the HA-2 antigen is only expressed by recipient hematopoietic cells. We hypothesize that low-dose triggering of the endogenous TCR due to the persistence of the virus will also boost the antileukemic immune response mediated via the HA-2-TCR.
To ensure persistence and correct homing of transduced virusspecific T cells, it is discussed that different memory subsets should be used (42, 43) , or virus-specific T cells responsible for the immunodominant response in the donor should be selected (21, 44) . Recent studies showed that distinct memory subsets are raised in different viral infections (45, 46) . Even within one virus-specific memory response, distinct subsets of virus-specific CD8 + T cells can be found. For example, the CD8 + memory T cells specific for EBV lytic antigens predominantly have a more differentiated effector memory phenotype, whereas CD8 + memory T cells specific for EBV latent antigens predominantly have a central memory phenotype (40) . Therefore, it is hypothesized that phenotype of CD8 + memory T cells could well be dictated by different routes of antigen exposure. Based on phenotypic characteristics, CD8 + memory T cells specific for CMV are mainly effector-type or late memory T cells (41) . However, studies have shown that CD8 + memory T cells specific for CMV are able to respond with renewed clonal expansion upon viral reactivation (23, 47) , suggesting that phenotypic classification alone is not indicative for functional characteristics. We therefore would like to use for clinical application a pool of CMV or EBV-specific T cells with distinct phenotypic characteristics, resulting in virus-specific T cells with different functional characteristics and homing capacities.
In conclusion, although after repetitive stimulation, HA-2-TCRtransferred CMV-specific T cells skew to populations predominantly expressing one TCR, all subsets are able to persist and repopulate after stimulation via the previously nontriggered TCR. Therefore, we conclude that TCR transduced virus specific T cells behave favorably in view of future clinical applications.
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